$CAVA
CAVA Group Inc

2024 Q3 Form 10-Q Financial Statement

#000162828024038276 Filed on August 23, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $233.5M
YoY Change 35.05%
Cost Of Revenue $155.2M
YoY Change 36.08%
Gross Profit $62.36M
YoY Change 37.26%
Gross Profit Margin 26.71%
Selling, General & Admin $28.28M
YoY Change 21.27%
% of Gross Profit 45.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $13.73M
YoY Change 28.24%
% of Gross Profit 22.02%
Operating Expenses $28.28M
YoY Change 21.27%
Operating Profit $16.14M
YoY Change 180.18%
Interest Expense $3.824M
YoY Change 447.07%
% of Operating Profit 23.69%
Other Income/Expense, Net $60.00K
YoY Change -49.15%
Pretax Income $20.03M
YoY Change 204.42%
Income Tax $287.0K
% Of Pretax Income 1.43%
Net Earnings $19.74M
YoY Change 201.9%
Net Earnings / Revenue 8.45%
Basic Earnings Per Share $0.17
Diluted Earnings Per Share $0.17
COMMON SHARES
Basic Shares Outstanding 114.1M shares
Diluted Shares Outstanding 118.3M shares

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $343.7M
YoY Change -2.58%
Cash & Equivalents $343.7M
Short-Term Investments
Other Short-Term Assets $4.934M
YoY Change 8.82%
Inventory $7.195M
Prepaid Expenses
Receivables $5.927M
Other Receivables $7.962M
Total Short-Term Assets $369.8M
YoY Change -1.29%
LONG-TERM ASSETS
Property, Plant & Equipment $355.0M
YoY Change 19.01%
Goodwill $1.944M
YoY Change 2.32%
Intangibles $1.355M
YoY Change 0.0%
Long-Term Investments
YoY Change
Other Assets $5.537M
YoY Change 10.34%
Total Long-Term Assets $668.8M
YoY Change 12.26%
TOTAL ASSETS
Total Short-Term Assets $369.8M
Total Long-Term Assets $668.8M
Total Assets $1.039B
YoY Change 7.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.35M
YoY Change 43.26%
Accrued Expenses $63.54M
YoY Change -4.29%
Deferred Revenue $4.357M
YoY Change 20.03%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $123.6M
YoY Change 7.76%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $123.6M
Total Long-Term Liabilities $0.00
Total Liabilities $443.1M
YoY Change 6.88%
SHAREHOLDERS EQUITY
Retained Earnings -$413.9M
YoY Change -9.33%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $595.4M
YoY Change
Total Liabilities & Shareholders Equity $1.039B
YoY Change 7.02%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income $19.74M
YoY Change 201.9%
Depreciation, Depletion And Amortization $13.73M
YoY Change 28.24%
Cash From Operating Activities $48.91M
YoY Change 128.22%
INVESTING ACTIVITIES
Capital Expenditures $26.20M
YoY Change -21.53%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$26.20M
YoY Change -21.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.083M
YoY Change -102.36%
NET CHANGE
Cash From Operating Activities 48.91M
Cash From Investing Activities -26.20M
Cash From Financing Activities -8.083M
Net Change In Cash 14.63M
YoY Change -95.57%
FREE CASH FLOW
Cash From Operating Activities $48.91M
Capital Expenditures $26.20M
Free Cash Flow $22.71M
YoY Change -290.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Entity File Number
EntityFileNumber
001-41721
dei Document Period End Date
DocumentPeriodEndDate
2024-07-14
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Address Address Line1
EntityAddressAddressLine1
14 Ridge Square NW
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 500
dei Entity Address City Or Town
EntityAddressCityOrTown
Washington
dei City Area Code
CityAreaCode
202
dei Local Phone Number
LocalPhoneNumber
400-2920
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
114320581 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
332428000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5927000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3662000 usd
CY2024Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
7962000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
369766000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
354912000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
355014000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
330730000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
304926000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
289451000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
1944000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5537000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5365000 usd
CY2024Q3 us-gaap Assets
Assets
1038542000 usd
CY2023Q4 us-gaap Assets
Assets
983757000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
20348000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
17234000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
63542000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
59219000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39711000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
319425000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
303615000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
225000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
443105000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
412955000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
95204000 shares
CY2022Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
662308000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-448503000 usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
343748000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
32583000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
123601000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
109036000 usd
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
79000 usd
us-gaap Net Income Loss
NetIncomeLoss
33734000 usd
us-gaap Depreciation
Depreciation
31055000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6949000 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-2120000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2265000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-261000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1558000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
143000 usd
cava Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
15588000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3764000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6022000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
22944000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
87295000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
45000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16093000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11320000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
332428000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39125000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
343748000 usd
cava Deferred Offering Costs Accrued Not Yet Paid
DeferredOfferingCostsAccruedNotYetPaid
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
166000 usd
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
662309000 usd
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-3426661
dei Entity Address State Or Province
EntityAddressStateOrProvince
DC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20016
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
CAVA
dei Entity Central Index Key
EntityCentralIndexKey
0001639438
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-29
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2500000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2500000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114306000 shares
CY2024Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
11000 usd
CY2023Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
11000 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1378000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1086000 shares
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
27066000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
9727000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1036421000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
570802000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1038542000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
983757000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
233495000 usd
dei Amendment Flag
AmendmentFlag
false
dei Entity Registrant Name
EntityRegistrantName
CAVA Group, Inc.
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
8223000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
7195000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
5637000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4934000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4962000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
1944000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1355000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1355000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
79000 usd
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114306000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
113708000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
113708000 shares
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1028181000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-413929000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-447663000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
595437000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
172894000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
492501000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
375977000 usd
CY2024Q3 us-gaap Cost Direct Material
CostDirectMaterial
68839000 usd
CY2023Q3 us-gaap Cost Direct Material
CostDirectMaterial
51000000 usd
us-gaap Cost Direct Material
CostDirectMaterial
142786000 usd
us-gaap Cost Direct Material
CostDirectMaterial
110118000 usd
CY2024Q3 us-gaap Cost Direct Labor
CostDirectLabor
58388000 usd
CY2023Q3 us-gaap Cost Direct Labor
CostDirectLabor
42417000 usd
us-gaap Cost Direct Labor
CostDirectLabor
124901000 usd
us-gaap Cost Direct Labor
CostDirectLabor
94571000 usd
CY2024Q3 us-gaap Occupancy Net
OccupancyNet
15917000 usd
CY2023Q3 us-gaap Occupancy Net
OccupancyNet
13400000 usd
us-gaap Occupancy Net
OccupancyNet
36339000 usd
us-gaap Occupancy Net
OccupancyNet
29999000 usd
CY2024Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
27991000 usd
CY2023Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
20646000 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
60749000 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
45294000 usd
CY2024Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
171135000 usd
CY2023Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
127463000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
364775000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
279982000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28281000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23321000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
62121000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
52345000 usd
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13733000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10709000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31055000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23568000 usd
CY2024Q3 us-gaap Restructuring Costs
RestructuringCosts
70000 usd
CY2023Q3 us-gaap Restructuring Costs
RestructuringCosts
1853000 usd
us-gaap Restructuring Costs
RestructuringCosts
352000 usd
us-gaap Restructuring Costs
RestructuringCosts
4068000 usd
CY2024Q3 us-gaap Pre Opening Costs
PreOpeningCosts
3302000 usd
CY2023Q3 us-gaap Pre Opening Costs
PreOpeningCosts
3400000 usd
us-gaap Pre Opening Costs
PreOpeningCosts
6681000 usd
us-gaap Pre Opening Costs
PreOpeningCosts
9399000 usd
CY2024Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-830000 usd
CY2023Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-386000 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-2120000 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-3105000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
217351000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
167132000 usd
us-gaap Costs And Expenses
CostsAndExpenses
467104000 usd
us-gaap Costs And Expenses
CostsAndExpenses
372467000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
16144000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
5762000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
25397000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3510000 usd
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3824000 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
699000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
8738000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
674000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
60000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
118000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
138000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
292000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20028000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6579000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
34273000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4476000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
287000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
539000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
19741000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
6539000 usd
us-gaap Net Income Loss
NetIncomeLoss
33734000 usd
us-gaap Net Income Loss
NetIncomeLoss
4398000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114130000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28366000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114040000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13098000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118291000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31279000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118088000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15212000 shares
CY2023Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
95204000 shares
CY2023Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
662308000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-451041000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1743000 usd
CY2023Q3 cava Adjustments To Additional Paid In Capital Shares Purchased Under Equity Plan
AdjustmentsToAdditionalPaidInCapitalSharesPurchasedUnderEquityPlan
246000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
98000 usd
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
29300000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
29300000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
336111000 usd
CY2023Q3 cava Temporary Equity Shares Conversion Of Convertible Securities
TemporaryEquitySharesConversionOfConvertibleSecurities
95204000 shares
CY2023Q3 cava Temporary Equity Value Conversion Of Convertible Securities
TemporaryEquityValueConversionOfConvertibleSecurities
662308000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
662309000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
6539000 usd
CY2023Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2023Q3 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
555809000 usd
CY2024Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2024Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
580810000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2954000 usd
CY2024Q3 cava Adjustments To Additional Paid In Capital Shares Purchased Under Equity Plan
AdjustmentsToAdditionalPaidInCapitalSharesPurchasedUnderEquityPlan
1232000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2024Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
9300000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
19741000 usd
CY2024Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2024Q3 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
595437000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2671000 usd
cava Adjustments To Additional Paid In Capital Shares Purchased Under Equity Plan
AdjustmentsToAdditionalPaidInCapitalSharesPurchasedUnderEquityPlan
289000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1466000 usd
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
29300000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
29300000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
336111000 usd
cava Temporary Equity Shares Conversion Of Convertible Securities
TemporaryEquitySharesConversionOfConvertibleSecurities
95204000 shares
cava Temporary Equity Value Conversion Of Convertible Securities
TemporaryEquityValueConversionOfConvertibleSecurities
662308000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
662309000 usd
us-gaap Net Income Loss
NetIncomeLoss
4398000 usd
CY2023Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2023Q3 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
555809000 usd
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2023Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
570802000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6949000 usd
cava Adjustments To Additional Paid In Capital Shares Purchased Under Equity Plan
AdjustmentsToAdditionalPaidInCapitalSharesPurchasedUnderEquityPlan
1291000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
17339000 usd
us-gaap Net Income Loss
NetIncomeLoss
33734000 usd
CY2024Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2024Q3 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
595437000 usd
us-gaap Net Income Loss
NetIncomeLoss
4398000 usd
us-gaap Depreciation
Depreciation
23541000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2671000 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-3105000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1499000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
2644000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
217000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1371000 usd
cava Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
18035000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-281000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
13944000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
20729000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
47110000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
59882000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
72478000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-59882000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-72478000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
6000000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
6000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
17339000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1466000 usd
cava Proceeds From Shares Purchased Under Equity Plan
ProceedsFromSharesPurchasedUnderEquityPlan
1291000 usd
cava Proceeds From Shares Purchased Under Equity Plan
ProceedsFromSharesPurchasedUnderEquityPlan
289000 usd
cava Underwriting Discounts And Commissions
UnderwritingDiscountsAndCommissions
22800000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
342604000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1922000 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
365000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
52000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
339088000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
313720000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
352845000 usd
cava Deferred Offering Costs Accrued Not Yet Paid
DeferredOfferingCostsAccruedNotYetPaid
3462000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
985000 usd
cava Increase Decrease In Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid
-2422000 usd
cava Increase Decrease In Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid
8727000 usd
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 usd
CY2024Q3 us-gaap Number Of Restaurants
NumberOfRestaurants
341 restaurant
CY2024Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
25 state
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q2 cava Temporary Equity Shares Conversion Of Convertible Securities
TemporaryEquitySharesConversionOfConvertibleSecurities
95200000 shares
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
233495000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
172894000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
492501000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
375977000 usd
CY2024Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
400000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
100000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1200000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
400000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
524735000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
472745000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
169721000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
142015000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
355014000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
330730000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
23521000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
23370000 usd
CY2024Q3 cava Accrued Capital Purchases Current
AccruedCapitalPurchasesCurrent
6164000 usd
CY2023Q4 cava Accrued Capital Purchases Current
AccruedCapitalPurchasesCurrent
7935000 usd
CY2024Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
8277000 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3807000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4357000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4096000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
21223000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20011000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
63542000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
59219000 usd
CY2024Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P10Y
CY2024Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
14134000 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
11689000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
28410000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
23153000 usd
CY2024Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13866000 usd
CY2023Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
20051000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
33397000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
33884000 usd
CY2024Q3 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
CY2023Q3 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
109000 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
2786000 usd
CY2024Q3 cava Number Of Irrevocable Letters Of Credit
NumberOfIrrevocableLettersOfCredit
4 letters_of_credit
CY2023Q4 cava Number Of Irrevocable Letters Of Credit
NumberOfIrrevocableLettersOfCredit
4 letters_of_credit
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3600000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8700000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1800000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3000000.0 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3078000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.45
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M18D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
97054000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
7000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
47.84
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
66000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.45
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
28000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
16.84
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2991000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.66
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M18D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
217091000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1770000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.35
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y7M6D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2991000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
11.66
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y3M18D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
217091000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
19741000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
6539000 usd
us-gaap Net Income Loss
NetIncomeLoss
33734000 usd
us-gaap Net Income Loss
NetIncomeLoss
4398000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114130000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28366000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114040000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13098000 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4161000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2913000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4048000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2114000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118291000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31279000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118088000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15212000 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
233495000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
172894000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
492501000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
375977000 usd
CY2024Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
171135000 usd
CY2023Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
127463000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
364775000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
279982000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
62360000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
45431000 usd
us-gaap Gross Profit
GrossProfit
127726000 usd
us-gaap Gross Profit
GrossProfit
95995000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
28281000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23321000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
62121000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
52345000 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
13733000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10709000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
31055000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
23568000 usd
CY2024Q3 us-gaap Restructuring Costs
RestructuringCosts
70000 usd
CY2023Q3 us-gaap Restructuring Costs
RestructuringCosts
1853000 usd
us-gaap Restructuring Costs
RestructuringCosts
352000 usd
us-gaap Restructuring Costs
RestructuringCosts
4068000 usd
CY2024Q3 us-gaap Pre Opening Costs
PreOpeningCosts
3302000 usd
CY2023Q3 us-gaap Pre Opening Costs
PreOpeningCosts
3400000 usd
us-gaap Pre Opening Costs
PreOpeningCosts
6681000 usd
us-gaap Pre Opening Costs
PreOpeningCosts
9399000 usd
CY2024Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-830000 usd
CY2023Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-386000 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-2120000 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-3105000 usd
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3824000 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
699000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
8738000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
674000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
60000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
118000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
138000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
292000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20028000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6579000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
34273000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4476000 usd
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-24-038276-index-headers.html Edgar Link pending
0001628280-24-038276-index.html Edgar Link pending
0001628280-24-038276.txt Edgar Link pending
0001628280-24-038276-xbrl.zip Edgar Link pending
cava-20240714.htm Edgar Link pending
cava-20240714.xsd Edgar Link pending
ex101cavaar2023equityincen.htm Edgar Link pending
ex3112024q2.htm Edgar Link pending
ex3122024q2.htm Edgar Link pending
ex3212024q2.htm Edgar Link pending
ex3222024q2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
cava-20240714_cal.xml Edgar Link unprocessable
cava-20240714_def.xml Edgar Link unprocessable
cava-20240714_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cava-20240714_lab.xml Edgar Link unprocessable
cava-20240714_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending